Background: Patients' knowledge regarding their oral anticoagulant (OAC) treatment
| INTRODUCTION
Atrial fibrillation (AF) is associated with significant morbidity and mortality, and stroke resulting from AF presents a large and growing economic concern.
1 Anticoagulation therapy in at risk patients with AF can markedly reduce stroke risk and is therefore an important component of AF management. 1 Under-use of OACs in AF is often reported in terms of under-prescribing of treatment, but poor treatment outcomes in people with AF also commonly result from poor adherence or persistence with anticoagulant therapy even when it is prescribed, often with devastating consequences. 2 Patients' oral anticoagulation knowledge, level of medication adherence and health literacy are known to affect treatment outcomes. However, contemporary data regarding the relationships between these variables are lacking.
Medication adherence in chronic disease is a worldwide problem. Up to 50% of patients are nonadherent to medications, including
OACs. [3] [4] [5] Limited health literacy is associated with poor warfarin and AF knowledge. 6, 7 In addition, poor warfarin knowledge and lack of education about warfarin have been associated with inadequate anticoagulant control and increased hemorrhagic events, and those at highest risk of stroke have been shown to have the poorest knowledge regarding their treatment. 6, 8, 9 It is unknown whether similar results will be seen in patients who take directly acting oral anticoagulants (DOACs).
The introduction of the DOACs has sought to address some of the pitfalls of warfarin therapy; however, there are persisting challenges to overcome, adherence to the drug regimen being the most crucial.
Due to their short half-lives, irregular or missed doses can increase the risk of stroke, as the patient will be inadequately anticoagulated during this time.
10,11
The 2016 European Society of Cardiology (ESC) guidelines for the management of AF recommend an integrated approach to care
with particular focus on the patient being central to effective management. Integral to patient-centered care is patient education, which in turn empowers self-management and shared decision-making. As a European Heart Rhythm Association, priority research area and acknowledged by the ESC guidelines, more research is needed to determine the best way to deliver an integrated approach.
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Given the interest in integrated AF care, and the lack of contemporary data investigating the relationships between health literacy, adherence behaviors, and medication knowledge of patients taking
OACs for stroke thromboprophylaxis in AF, the aim of this study was to investigate the relationships between these variables and to assess the strength of the relationship between knowledge and health literacy.
| METHODS

| Recruitment
Participants were recruited to the study from participating general practices or outpatient cardiologist clinics in Tasmania, Australia. Invitation letters with a response form were sent to the practices requesting their participation in the study and asking that patients with AF in their practices be given the opportunity to participate in the study. To be eligible to participate, participants had to be over 18 years of age, have a diagnosis of nonvalvular AF, be currently taking warfarin or DOACs for stroke thromboprophylaxis, and be able to provide informed consent.
Participants were interviewed either at their regular GP surgery or in their home as these were considered familiar and comfortable surroundings. A $10 AUD shopping voucher was provided to all participants as recruitment incentive and as compensation for their time at the end of the interview.
| Data collection
The interview consisted of four validated questionnaires-the 8-item Participants were introduced to the study using a script, and all questionnaires were undertaken in an interview style, with the exception of s-TOFHLA which participants completed by themselves within a seven-minute time limit. Each interview took between 20 and 45 minutes, and all were completed in a single session.
| Adherence
To assess self-reported adherence behavior, we used the MMAS-8 questionnaire, which asks seven dichotomous questions and one 5-point Likert scale question. [13] [14] [15] The validated MMAS-8 was chosen
as it has been shown to be a reliable predictor of adherence in patients taking medications for chronic diseases, such as antihypertensives, and has been used to assess adherence in those taking OACs.
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In assessing adherence using the MMAS-8, a score of 8 was considered adequate adherence, while a score of less than 8 was considered inadequate adherence. 
| Knowledge
To assess the level of knowledge of OAC therapy and its role, including participant perceptions/understanding of the risks and benefits, we used the AKT, which was developed to assess the anticoagulant knowledge of patients taking either warfarin or DOACs. A score of "1" or "0" was given for correct and incorrect answers, respectively. Participants taking a DOAC were required to answer only section "A" with a total maximum score of 25, and participants taking warfarin were required to answer sections "A" and "B" with a total maximum score of 35. Final scores were presented as percentages of correct answers for all participants. 
| Health literacy
To assess functional health literacy, we used the s-TOFHLA.
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Dichotomous scoring of "1" for correct answers and "0" for incorrect answers was used, and a maximum score of 36 could be achieved. In scoring the s-TOFHLA scale, a score of 23 and above was considered adequate health literacy, while a score of 22 and less was considered inadequate health literacy.
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| Quality of life
To assess AF-specific health-related quality of life, we used the AFEQT. For AFEQT questions 1-20, responses were scored on a 1-point to 7-point Likert scale. An overall score of 0-100 could be achieved, corresponding to "complete disability" to "no disability,"
respectively. AFEQT was chosen as it combines the scores from four parameters: symptoms, daily activities, treatment concerns, and satisfaction to a single measure with reliability, and has focused questions surrounding the use of anticoagulants.
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| Statistical analysis
Statistical analysis was performed using SPSS version 24 (IBM, Armonk, New York, USA).
Means and standard deviations were used to summarize continuous variables, and independent sample t tests were used for inferential statistics. s-TOFHLA and MMAS-8 scores were analyzed as both continuous and dichotomous variables. Correlations between AKT, s-TOFHLA, and MMAS-8 scores were determined using the Spearman rank coefficient. Logistic regression analysis was used to estimate regression coefficients for AKT and s-TOFHLA against MMAS-8 adherence scores in both univariate and multivariate models. A P value of <.05 was considered statistically significant for all analyses.
| Sample size
Using a 5% margin of error and statistical power of 80%, we determined that a sample size of 40 participants would be sufficient to detect a moderate statistical correlation of 0.4 between the AKT score and s-TOFHLA score with the MMAS-8 adherence score.
| Ethics
The Tasmanian Health and Medical Human Research Ethics Committee (Reference number H0015395) approved this study. Informed consent was obtained from all individual participants included in the study.
| RESULTS
| Demographic characteristics
Fifty participants were interviewed. The results of two participants were excluded because they had discontinued their OAC at the time of the interview, leaving data from 48 participants available for analysis. The average age of the participants was 76.4 ± 8.7 years, and the majority (77.1%) were male (Table 1) . Forty-two percent of participants had either high school education (Year 10 equivalent) or college (Year 12 equivalent) as the highest level of education completed.
The majority of the participants were taking a DOAC (64.6%) at the time of the study and had been taking an anticoagulant for >2 years (75.0%).
| Association between level of self-reported adherence and health literacy, knowledge and AF-related quality of life
Adequate adherence to the prescribed OAC was reported by 47.9% of participants, and this group had a significantly higher total knowledge score than those who were nonadherent (67.5% vs 56.1%, P = .011; Table 2 ). However, no association between the level of adherence with health literacy and AF-related quality of life was observed.
| Level of health literacy and knowledge
As shown in Table 3 , when participants were categorized based on their health literacy scores, those with inadequate health literacy had a significantly lower mean total anticoagulant knowledge score than those with adequate health literacy (55.8 ± 15.9 vs 66.1 ± 14.4, P = .02). Furthermore, participants with inadequate health literacy were less likely than those with adequate health literacy to know why they had been prescribed an OAC (57.1% vs 85.2%, P = .04), less likely to know how the medication worked (42.9% vs 88.9%, P = .001) and less likely to be able to describe one sign of side effects to watch out for while taking an anticoagulant (28.6% vs 70.4%, P = .03). In addition, only 16.7% of all participants could mention three signs of side effects to watch out for while taking an OAC (Table 3) .
| Association between adherence, knowledge, and health literacy
There were moderate positive correlations between the mean scores of self-reported adherence, anticoagulant knowledge, and health literacy ( Figure 1 ). Multivariate analysis showed that anticoagulation knowledge was significantly associated with MMAS-8 score even after adjusting for health literacy score (OR, 1.050; 95% CI, 1.003-1.100; P = .036) ( Table 4 ). There were no statistically significant relationships between total AF-specific health-related quality of life scores and other study variables.
T A B L E 1 Demographic characteristics n (%) Mapping the results from this study to the COM-B framework suggests each of the domains (COM) is involved and needs to be addressed in order to increase OAC adherence (B).
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Poor adherence to OACs is frequently reported in the literature and has been associated with poor clinical outcomes. 2, 4, 5, 25, 26 In our study, 48% of participants reported adequate adherence to their prescribed OAC. This is similar to the study by Davis et al. 4 in patients taking warfarin, in which only 50% of participants reported adequate adherence.
A recent review of adherence and persistence to OACs in AF found that in the studies available, poor adherence is associated with poor treatment outcomes such as stroke and bleeding. 26 Yao et al.
recently
undertook a large retrospective cohort study in patients taking OACs for stroke prevention in AF and found that those with a high estimated stroke risk were at an increased risk of stroke when they were not taking anticoagulation for 6 months or more (hazard ratio 2.73, P < .001),
clearly indicating that better medication taking behavior leads to better outcomes.
Taking into consideration the importance of adherence in en- 
23,24
We observed a total mean knowledge score of 62%. This is similar to the result of other studies in the literature, where a mean knowledge score of <70% has been reported in different populations. 18, [27] [28] [29] From the results of our study, participants who were considered adherent had a significantly higher mean total knowledge score than those who were nonadherent, and knowledge remained significantly associated with adherence even after adjusting for the level of health literacy. however, this has been demonstrated in those taking warfarin. 6, 8, 9 Our study reveals specific deficiencies in the knowledge of both warfarin and DOAC-taking participants. In addition, it provides a platform to inform the development of educational interventions and justifies the need for further research in this area.
Limited health literacy may be an indicator of deficits in warfarin knowledge. 6, 7 Fang et al. 6 reported that 67% of patients taking warfa- 
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Lack of knowledge and health literacy, comprehension of the disease and treatment, perception of illness and beliefs about treatment including concern of side effects and bleeding fit within the
COM-B subcategories of Psychological Capability and Reflective
Motivation. 23, 24 It has been suggested that these categories can be addressed by HCPs giving information to patients to shape their Will drinking too much alcohol increase the risk of side effects with this medicine?
18 (37.5) 9 (42.9) 9 (33.3) .513
Is it necessary to inform a surgeon, dentist or other health professional that you are taking this medicine before undergoing surgery or a procedure?
47 (97.9) 20 (95.2) 27 (100.0) .329
Is it important that all the health care practitioners you see know that you are taking this medicine? 
| LIMITATIONS
There are a number of limitations to this study, including the crosssectional methodology and small sample size. Furthermore, we did not collect information on the quality of education given to participants on their OACs upon initiation, nor did we determine whether participants who were taking a DOAC at the time of the interview had previously been taking warfarin. The limitations of the tools used should also be considered. We anecdotally observed that many participants were unable to differentiate between the effect of AF and other comorbidities such as heart failure or older age on quality of life. by self-report; this approach can possibly overestimate the level of adherence observed. 32 
| IMPLICATIONS FOR FURTHER RESEARCH
Recent clinical guidelines have placed emphasis on integrating the patient and their preferences into AF management to improve outcomes. 1 The results of this study help to inform the implementation of patient-centered integrated AF management and reinforce the need for additional research. Considering the demonstrated correlation between health literacy, knowledge, and adherence, larger studies are required to determine whether improving these patientcentered aspects of OAC management in AF leads to improved treatment outcomes. Moreover, this study reveals gaps in the knowledge of participants taking OACs. A large prospective study assessing anticoagulant knowledge in this population will be useful in identifying specific areas of lacking knowledge to improve OAC education.
| CONCLUSION
In conclusion, the results of this study demonstrate a significant relationship between health literacy, OAC knowledge, and self-reported adherence behaviors. They also highlight inadequate medication adherence behavior and health literacy levels, and gaps in patient oral anticoagulation knowledge. To adopt a true patient-centered approach to AF management, it is important for HCPs to consider these variables in patients taking OACs for stroke prevention in AF.
Interventions designed to optimize the outcomes of anticoagulant treatment need to address these factors. 
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